Holen Sie sich die Stockscreener-App
6.76
3.98%
-0.28
Schlusskurs vom Vortag:
$7.04
Offen:
$7.08
24-Stunden-Volumen:
376.44K
Relative Volume:
0.34
Marktkapitalisierung:
$209.57M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.25M
KGV:
-5.6998
EPS:
-1.186
Netto-Cashflow:
$-22.80M
1W Leistung:
-4.92%
1M Leistung:
-29.21%
6M Leistung:
+92.59%
1J Leistung:
+98.82%
1-Tages-Spanne:
$6.75
$7.1604
1-Wochen-Bereich:
$6.75
$7.35
52-Wochen-Spanne:
$1.73
$11.41
Sagimet Biosciences Inc Stock (SGMT) Company Profile
Firmenname
Sagimet Biosciences Inc
Sektor
Branche
Telefon
(650) 561-8600
Adresse
155 BOVET RD., SUITE 303, SAN MATEO
Vergleichen Sie SGMT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGMT
Sagimet Biosciences Inc
|
6.76 | 231.88M | 0 | -29.25M | -22.80M | -1.186 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Eingeleitet | Wedbush | Outperform |
| 2025-08-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-07-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-12-06 | Eingeleitet | Oppenheimer | Outperform |
| 2024-11-12 | Eingeleitet | UBS | Buy |
| 2024-06-28 | Herabstufung | Goldman | Buy → Neutral |
| 2024-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-03-25 | Eingeleitet | Leerink Partners | Outperform |
| 2023-08-08 | Eingeleitet | Goldman | Buy |
| 2023-08-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-08-08 | Eingeleitet | Piper Sandler | Overweight |
| 2023-08-08 | Eingeleitet | TD Cowen | Outperform |
Alle ansehen
Sagimet Biosciences Inc Aktie (SGMT) Neueste Nachrichten
Will Sagimet Biosciences Inc. benefit from macro trendsQuarterly Growth Report & AI Powered Market Entry Ideas - Newser
Can volume confirm reversal in Sagimet Biosciences Inc.July 2025 Retail & Capital Efficiency Focused Ideas - Newser
Forecasting Sagimet Biosciences Inc. price range with options data2025 Market Sentiment & Reliable Intraday Trade Alerts - Newser
What’s the recovery path for long term holders of Sagimet Biosciences Inc.Earnings Miss & Consistent Profit Trading Strategies - Newser
Does Sagimet Biosciences Inc. qualify in momentum factor screeningWeekly Loss Report & Community Verified Swing Trade Signals - Newser
Real time social sentiment graph for Sagimet Biosciences Inc.Global Markets & Risk Controlled Daily Plans - Newser
How to track smart money flows in Sagimet Biosciences Inc.Quarterly Profit Summary & Daily Volume Surge Signals - Newser
Will Sagimet Biosciences Inc. stock go up soonMarket Growth Report & Expert Approved Momentum Trade Ideas - Newser
Sagimet Biosciences (NASDAQ:SGMT) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Alyeska Investment Group L.P. Trims Stock Position in Sagimet Biosciences Inc. $SGMT - MarketBeat
Sagimet Biosciences to Present at the 9th Annual MASH Drug Development Summit on Innovations in Metabolic Dysfunction and Fibrosis Treatment - Quiver Quantitative
Sagimet Biosciences Announces Upcoming Presentations at 9th Annual MASH Drug Development Summit - GlobeNewswire
Sagimet Biosciences Announces Upcoming Presentations at 9th Annual MASH Drug Development Summit - GlobeNewswire Inc.
Price action breakdown for Sagimet Biosciences Inc.July 2025 Big Picture & Smart Allocation Stock Tips - Newser
Will Sagimet Biosciences Inc. Benefit From Broader Market BounceJuly 2025 Setups & Daily Entry Point Trade Alerts - beatles.ru
Can Sagimet Biosciences Inc. continue delivering strong returnsJuly 2025 Closing Moves & Comprehensive Market Scan Reports - beatles.ru
Is Sagimet Biosciences Inc. attractive at current valuation2025 Volume Leaders & Weekly Watchlist of Top Performers - خودرو بانک
Sagimet Biosciences shares fall 1.55% after-hours following presentation at Cantor Global Healthcare Conference. - AInvest
What indicators show strength in Sagimet Biosciences Inc.July 2025 Analyst Calls & Safe Capital Growth Plans - Newser
Sagimet Biosciences’ Strategic Positioning in the Biotech Sector - AInvest
Sagimet Biosciences Presents at Cantor Global Healthcare Conference 2025 - AInvest
Transcript : Sagimet Biosciences Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-03-2025 01 - MarketScreener
Sagimet Biosciences Inc.’s volatility index tracking explainedWeekly Trade Report & Smart Investment Allocation Tips - Newser
Is Sagimet Biosciences Inc. stock bottoming outGlobal Markets & Risk Adjusted Swing Trade Ideas - Newser
Is Sagimet Biosciences Inc. a strong candidate for buy and hold2025 Retail Activity & Smart Allocation Stock Tips - خودرو بانک
News impact scoring models applied to Sagimet Biosciences Inc.Portfolio Gains Summary & Daily Growth Stock Investment Tips - Newser
Earnings visualization tools for Sagimet Biosciences Inc.Day Trade & Real-Time Stock Price Movement Reports - Newser
Real time scanner hits for Sagimet Biosciences Inc. explainedJuly 2025 Trends & Weekly Return Optimization Alerts - Newser
How high can Sagimet Biosciences Inc. stock price go in 20252025 Market Sentiment & Free Community Supported Trade Ideas - Newser
What is the Moat Score of Sagimet Biosciences Inc.2025 AllTime Highs & Expert Verified Movement Alerts - خودرو بانک
Technical Bounce Expected in Sagimet Biosciences Inc. Next Week2025 Performance Recap & Stepwise Entry and Exit Trade Signals - beatles.ru
Applying sector rotation models to Sagimet Biosciences Inc.July 2025 PostEarnings & Pattern Based Trade Signal System - Newser
Is Sagimet Biosciences Inc. gaining market shareTrend Reversal & Free High Accuracy Swing Entry Alerts - خودرو بانک
How to build a dashboard for Sagimet Biosciences Inc. stockMarket Sentiment Report & Technical Pattern Alert System - Newser
How high can Sagimet Biosciences Inc. stock go2025 Market Overview & Daily Risk Controlled Trade Plans - Newser
Is Sagimet Biosciences Inc. stock a buy or sellMarket Risk Analysis & Reliable Price Breakout Alerts - خودرو بانک
Can Sagimet Biosciences Inc. deliver consistent dividendsJuly 2025 Market Mood & Reliable Intraday Trade Plans - خودرو بانک
Is Sagimet Biosciences Inc. meeting your algorithmic filter criteriaLong Setup & Real-Time Chart Breakout Alerts - Newser
Is Sagimet Biosciences Inc. stock a good pick for beginnersJuly 2025 Analyst Calls & Real-Time Volume Analysis Alerts - خودرو بانک
Sagimet Biosciences Inc. stock momentum explained2025 Investor Takeaways & Free Fast Entry Momentum Trade Alerts - Newser
How to monitor Sagimet Biosciences Inc. with trend dashboardsAnalyst Upgrade & Breakout Confirmation Alerts - Newser
Using data filters to optimize entry into Sagimet Biosciences Inc.Quarterly Growth Report & Free Safe Capital Growth Stock Tips - Newser
Tools to monitor Sagimet Biosciences Inc. recovery probabilityWeekly Trade Report & Community Consensus Picks - Newser
Momentum Screeners Rank Sagimet Biosciences Inc. in Top 5 TodayJuly 2025 Pullbacks & Advanced Technical Analysis Signals - beatles.ru
Sagimet Biosciences: Strong Pipeline Progress, Funding Overhang Keeps Stock at Hold - AInvest
Finanzdaten der Sagimet Biosciences Inc-Aktie (SGMT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sagimet Biosciences Inc-Aktie (SGMT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Martins Eduardo Bruno | Chief Medical Officer |
Jul 21 '25 |
Sale |
9.13 |
8,277 |
75,607 |
106,936 |
| Rozek Elizabeth | General Counsel and CCO |
Jul 21 '25 |
Sale |
9.13 |
10,780 |
98,471 |
183,726 |
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):